Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
valganciclovir (valcyte) (1 trial)
omega-3 fatty acids (omacor) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
HIV Infections (Phase 2)
Immune Reconstitution Inflammatory Syndrome (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Kaposi (Phase 2)
Trials (2 total)
Trial APIs (2 total)